financetom
Business
financetom
/
Business
/
Poland's Pekao, PZU sign memorandum for potential merger
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Poland's Pekao, PZU sign memorandum for potential merger
Jun 2, 2025 1:34 AM

June 2 (Reuters) - Polish bank Pekao has signed

a memorandum with insurer PZU to prepare a potential

merger deal to create one of the biggest financial institutions

in Europe.

Ahead of the potential deal, PZU would be split into a

holding company and a wholly-owned unit running its operational

insurance activity, Pekao said on Monday.

Thereafter, the holding company would be merged with Pekao,

the lender added.

Currently, PZU holds a 20% stake in Pekao, Poland's second

biggest lender.

The news comes amid expectations of consolidation in the

Polish banking sector. In recent moves, Austria's Erste Group

Bank bought the Polish arm of Spain's Santander for

6.8 billion euros ($7.8 billion), while Citigroup's ( C/PN ) Polish

unit agreed to sell its consumer banking business in the country

to Velobank.

The announcement also came after nationalist opposition

candidate Karol Nawrocki narrowly won Poland's presidential

election on Sunday, a major blow to the centrist government's

efforts to cement Warsaw's pro-European orientation.

Pekao and PZU aim to complete the possible deal by the end

of June 2026, which they said could free up about 15 billion to

20 billion zlotys ($4 billion to $5.3 billion) of the group's

capital surpluses.

The surplus would increase dividend potential of the

combined companies, Pekao added.

The potential deal depends on a number of factors, including

the entry into force of relevant legislative changes, as well as

regulatory and shareholder approvals.

Both brands will maintain their "identity, distinctiveness

and autonomy of activity" in their respective business areas,

Pekao said, but added the group would be led by a bank, not an

insurer.

The companies also plan to develop an optimal strategy for

Alior Bank, in which Pekao has a 32% stake, the lender

added.

($1 = 3.7460 zlotys)

($1 = 0.8751 euros)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Harmony Biosciences' genetic disorder drug fails to meet main goal in late-stage trial
Harmony Biosciences' genetic disorder drug fails to meet main goal in late-stage trial
Sep 24, 2025
Sept 24 (Reuters) - Harmony Biosciences ( HRMY ) said on Wednesday its experimental drug for a type of rare genetic disorder failed to meet the main goal in a late-stage trial. ...
Two US senators urge Tinder parent to act against dating scams on its apps
Two US senators urge Tinder parent to act against dating scams on its apps
Sep 24, 2025
(Reuters) -Two U.S. senators sent a letter to Tinder parent Match on Wednesday, pushing for action against dating scams on the company's platforms and asking for information about its efforts to detect frauds and protect its users. In a letter to Match CEO Spencer Rascoff, Democratic Senator Maggie Hassan and Republican Senator Marsha Blackburn asked the company to provide documents...
Freeport-McMoRan expects lower consolidated sales for copper, gold in third quarter
Freeport-McMoRan expects lower consolidated sales for copper, gold in third quarter
Sep 24, 2025
Sept 24 (Reuters) - Miner Freeport-McMoRan said on Wednesday that it was expecting consolidated sales to be about 4% lower for copper and nearly 6% lower for gold in the third quarter, compared with its prior forecast. (Reporting by Pooja Menon in Bengaluru; Editing by Anil D'Silva) ...
Biogen Says Leqembi Approved in Australia as Treatment for Alzheimer's Disease; Shares Up Pre-Bell
Biogen Says Leqembi Approved in Australia as Treatment for Alzheimer's Disease; Shares Up Pre-Bell
Sep 24, 2025
08:11 AM EDT, 09/24/2025 (MT Newswires) -- Biogen (BIIB) and Eisai said Wednesday that Australia's Therapeutic Goods Administration approved Leqembi for the treatment of mild cognitive impairment and mild dementia due to Alzheimer's disease. The approval follows a review process after the regulatory agency initially did not approve the drug in February, the company said. Leqembi targets toxic protofibrils and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved